Menold Daniel
Insider CIK 1705745 · CBAY Vice President, Finance
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2024-01-16 | 2024-01-16 | 10,000 | — | $0 | 135,109 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2024-01-16 | 2024-01-16 | 10,000 | $23.58 | $235.8K | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2024-01-16 | 2024-01-16 | 10,000 | $4.05 | $40.5K | 10,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-12-15 | 2023-12-15 | 11,497 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-12-15 | 2023-12-15 | 10,000 | — | $0 | 145,109 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-12-15 | 2023-12-15 | 10,000 | $4.05 | $40.5K | 10,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-12-15 | 2023-12-15 | 11,497 | $21.99 | $252.8K | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-12-15 | 2023-12-15 | 10,000 | $21.98 | $219.8K | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-12-15 | 2023-12-15 | 11,497 | $8.43 | $96.9K | 11,497 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-11-15 | 2023-11-17 | 17,500 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-11-15 | 2023-11-17 | 17,500 | $3.45 | $60.4K | 17,500 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-11-15 | 2023-11-17 | 0 | $17.38 | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-10-16 | 2023-10-18 | 17,500 | — | $0 | 17,500 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-10-16 | 2023-10-18 | 0 | $13.76 | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-10-16 | 2023-10-18 | 17,500 | $3.45 | $60.4K | 17,500 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-09-15 | 2023-09-19 | 15,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-09-15 | 2023-09-19 | 1,545 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-09-15 | 2023-09-19 | 0 | $16.87 | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-09-15 | 2023-09-19 | 15,000 | $1.72 | $25.8K | 15,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-09-15 | 2023-09-19 | 0 | $16.87 | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-09-15 | 2023-09-19 | 1,545 | $1.82 | $2.8K | 1,545 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-08-15 | 2023-08-16 | 8,500 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-08-15 | 2023-08-16 | 7,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-08-15 | 2023-08-16 | 0 | $11.92 | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-08-15 | 2023-08-16 | 7,000 | $10.00 | $70.0K | 7,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-08-15 | 2023-08-16 | 0 | $12.13 | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-08-15 | 2023-08-16 | 8,500 | $1.06 | $9.0K | 8,500 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-08-09 | 2023-08-11 | 6,486 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-08-09 | 2023-08-11 | 14,459 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-08-09 | 2023-08-11 | 20,945 | $12.35 | $258.7K | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-08-09 | 2023-08-11 | 20,945 | $5.00 | $104.7K | 20,945 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2023-01-25 | 2023-01-27 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2022-01-25 | 2022-01-27 | 75,000 | — | $0 | 75,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2021-01-06 | 2021-01-28 | 42,000 | — | $0 | 42,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2020-05-15 | 2020-05-19 | 180,564 | — | $0 | 180,564 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2019-01-29 | 2019-01-31 | 69,156 | — | $0 | 69,156 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2018-08-29 | 2018-08-31 | 5,000 | — | $0 | 14,459 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2018-08-29 | 2018-08-31 | 5,000 | $13.00 | $65.0K | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2018-08-29 | 2018-08-31 | 5,000 | $5.00 | $25.0K | 5,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2018-01-24 | 2018-01-26 | 62,500 | — | $0 | 62,500 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2017-05-03 | 2017-05-05 | 35,000 | — | $0 | 35,000 | SEC↗ |